RxDoctor Payments DataLook up a doctor →

RYBELSUS: payments to doctors

Payments that named RYBELSUS as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$52.3M
Providers
150,288
Transactions
1,605,787
Average per transaction
$33

The per-transaction average — $33 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 150,288 providers the average total is $348, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Novo Nordisk$52,214,66199.8%
Novo Nordisk AS$91,0790.2%
← All drugs & devices